Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Clinical Nutrition|November 27, 2015
Lipid-based nutrient supplements for pregnant women reduce newborn stunting in a cluster-randomized controlled effectiveness trial in BangladeshMalay K Mridha, Susana L Matias, Camila M Chaparro, et al.
Microbiology Resource Announcements|July 10, 2026
Characterization of fungal communities in Guánica State Forest caves utilizing internal transcribed spacer sequencingPeter A Camacho-Nazario, Camila M Martínez-Llaurador, Isabel Aguirre-Ortiz, et al.
Current Developments in Nutrition|March 1, 2021
Comprehensive Evaluation of Metabolites and Minerals in 6 Microgreen Species and the Influence of MaturitySarah A Johnson, Jessica E Prenni, Adam L Heuberger, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2011
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyM Chaparro, P Burgueño, E Iglesias, et al.
Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Digestive Diseases and Sciences|September 13, 2013
Health care costs of complex perianal fistula in Crohn's diseaseM Chaparro, C Zanotti, P Burgueño, et al.
Mucosal Immunology|May 11, 2018
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel diseaseD Bernardo, A C Marin, S Fernández-Tomé, et al.
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Pageof 10